Login
Revance Therapeutics Inc is not yet matched to a CUSIP, so institutional (13F) holdings cannot be attributed to it. The sections below that come from its own filings still apply.

Who owns Revance Therapeutics Inc?

Shares outstanding is not known for Revance Therapeutics Inc, so ownership cannot be shown as a share of the company.

Institutional ownership
—
Institutional holders
0
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Shares outstanding is not known for Revance Therapeutics Inc, so ownership cannot be shown as a share of the company.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Revance Therapeutics Inc in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Revance Therapeutics Inc.

How patient are the owners?

No 13F manager reports holding Revance Therapeutics Inc.

Super Investors

Investment managers reporting Revance Therapeutics Inc on Form 13F
No 13F manager reports holding Revance Therapeutics Inc yet.

Institutional Funds

Mutual funds and ETFs reporting Revance Therapeutics Inc on Form N-PORT
No fund reports holding Revance Therapeutics Inc yet.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support